242 related articles for article (PubMed ID: 23408967)
21. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.
Meng Q; Shi S; Liang C; Liang D; Hua J; Zhang B; Xu J; Yu X
Oncogene; 2018 Nov; 37(44):5843-5857. PubMed ID: 29980787
[TBL] [Abstract][Full Text] [Related]
23. Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro.
Banerjee J; Al-Wadei HA; Al-Wadei MH; Dagnon K; Schuller HM
BMC Cancer; 2014 Sep; 14():725. PubMed ID: 25260978
[TBL] [Abstract][Full Text] [Related]
24. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.
Ou YQ; Zhu Wb; Li Y; Qiu PX; Huang YJ; Xie J; He SM; Zheng XK; Leng TD; Xu D; Yan GM
Acta Pharmacol Sin; 2010 Jan; 31(1):73-80. PubMed ID: 19966835
[TBL] [Abstract][Full Text] [Related]
25. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of GSK 3β activity is associated with excessive EZH2 expression and enhanced tumour invasion in nasopharyngeal carcinoma.
Ma R; Wei Y; Huang X; Fu R; Luo X; Zhu X; Lei W; Fang J; Li H; Wen W
PLoS One; 2013; 8(7):e68614. PubMed ID: 23874688
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway.
Ma S; Li Q; Pan F
Int J Clin Oncol; 2015 Jun; 20(3):525-30. PubMed ID: 25145299
[TBL] [Abstract][Full Text] [Related]
28. Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.
Kato A; Naiki-Ito A; Nakazawa T; Hayashi K; Naitoh I; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Mori T; Tsutsumi M; Kuno T; Suzuki S; Kato H; Ohara H; Joh T; Takahashi S
Oncotarget; 2015 Dec; 6(40):42963-75. PubMed ID: 26556864
[TBL] [Abstract][Full Text] [Related]
29. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
30. Redox-sensitive glycogen synthase kinase 3β-directed control of mitochondrial permeability transition: rheostatic regulation of acute kidney injury.
Wang Z; Ge Y; Bao H; Dworkin L; Peng A; Gong R
Free Radic Biol Med; 2013 Dec; 65():849-858. PubMed ID: 23973862
[TBL] [Abstract][Full Text] [Related]
31. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.
Kobayashi T; Shimura T; Yajima T; Kubo N; Araki K; Tsutsumi S; Suzuki H; Kuwano H; Raz A
Int J Cancer; 2011 Dec; 129(12):2775-86. PubMed ID: 21448903
[TBL] [Abstract][Full Text] [Related]
32. Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity.
Treviño JG; Verma M; Singh S; Pillai S; Zhang D; Pernazza D; Sebti SM; Lawrence NJ; Centeno BA; Chellappan SP
Mol Cancer Ther; 2013 Dec; 12(12):2722-34. PubMed ID: 24107447
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
34. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.
Nagaraj NS; Washington MK; Merchant NB
Clin Cancer Res; 2011 Feb; 17(3):483-93. PubMed ID: 21266529
[TBL] [Abstract][Full Text] [Related]
35. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
Clin Cancer Res; 2005 May; 11(9):3433-8. PubMed ID: 15867245
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.
Xu W; Ge Y; Liu Z; Gong R
Am J Pathol; 2014 Oct; 184(10):2742-56. PubMed ID: 25239564
[TBL] [Abstract][Full Text] [Related]
37. Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy.
Domoto T; Pyko IV; Furuta T; Miyashita K; Uehara M; Shimasaki T; Nakada M; Minamoto T
Cancer Sci; 2016 Oct; 107(10):1363-1372. PubMed ID: 27486911
[TBL] [Abstract][Full Text] [Related]
38. GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Abrams SL; Akula SM; Meher AK; Steelman LS; Gizak A; Duda P; Rakus D; Martelli AM; Ratti S; Cocco L; Montalto G; Cervello M; Ruvolo P; Libra M; Falzone L; Candido S; McCubrey JA
Cells; 2021 Apr; 10(4):. PubMed ID: 33917370
[TBL] [Abstract][Full Text] [Related]
39. Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair.
Kausar T; Schreiber JS; Karnak D; Parsels LA; Parsels JD; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
Neoplasia; 2015 Oct; 17(10):757-66. PubMed ID: 26585231
[TBL] [Abstract][Full Text] [Related]
40. Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.
Mai W; Kawakami K; Shakoori A; Kyo S; Miyashita K; Yokoi K; Jin M; Shimasaki T; Motoo Y; Minamoto T
Clin Cancer Res; 2009 Nov; 15(22):6810-9. PubMed ID: 19903789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]